Legal News

MHRA publishes statement on coronavirus (COVID-19) booster vaccines

Published on: 15 September 2021
Published by LNB News

LNB News 15/09/2021

Document Information

Issue Date: 15 September 2021

Published Date: 15 September 2021

Jurisdiction(s): England, Northern Ireland, Scotland and Wales

Article summary

The Medicines and Healthcare products Regulatory Agency’s (MHRA) Chief Executive, Dr June Raine, has published a statement on the coronavirus (COVID-19) booster vaccine programme for winter 2021–2022. The statement calls the booster programme an ‘important regulatory change’ for providing more options for the vaccination programme. The regulatory decision was made after a review by the MHRA and the Commission on Human Medicines on the waning effectiveness of the vaccine after the second dose. Booster vaccines can be delivered at the same time as flu vaccines and the approved vaccines are Pfizer, Astrazeneca and Moderna.

Popular documents